Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Arimidex
Estrogen-Receptor Positive Breast Cancer
National Cancer Institute (NCI)
P3
B
(63)
Botensilimab
Colorectal Cancer
National Cancer Institute (NCI)
P3
B
(63)
cc-5013
Plasma Cell Leukemia
National Cancer Institute (NCI)
P3
B
(63)
Cedazuridine
Myelodysplastic Syndrome
National Cancer Institute (NCI)
P3
B
(63)
Cediranib
Ovarian Serous Tumor
National Cancer Institute (NCI)
P3
B
(63)
DEXAMETHASONE
Plasma Cell Leukemia
National Cancer Institute (NCI)
P3
B
(63)
Docetaxel
Head And Neck Cancer
National Cancer Institute (NCI)
P3
B
(63)
Durvalumab
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
P3
B
(63)
ERIBULIN MONOMETHANESULFONATE
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)
P3
B
(63)
FILGRASTIM
Plasma Cell Leukemia
National Cancer Institute (NCI)
P3
B
(63)
Romidepsin
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
National Cancer Institute (NCI)
P3
B
(63)
Romidepsin
Secondary Acute Myeloid Leukemia
National Cancer Institute (NCI)
P3
B
(63)
TACROLIMUS
Leukemia
National Cancer Institute (NCI)
P3
B
(63)
Benadryl
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
Busulphan
Hematopoietic And Lymphoid System Neoplasm
National Cancer Institute (NCI)
P2
B
(63)
Cediranib
Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(63)
Cediranib
Progesterone Receptor Negative
National Cancer Institute (NCI)
P2
B
(63)
CIS-DIAMMINEDICHLOROPLATINUM II
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
B
(63)
CIS-DIAMMINEDICHLOROPLATINUM II
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
B
(63)
Cyclophosphamide
Digestive System Cancer
National Cancer Institute (NCI)
P2
B
(63)
Cyclophosphamide
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
B
(63)
DEXAMETHASONE
Urethral Cancer
National Cancer Institute (NCI)
P2
B
(63)
ETOPOSIDE
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
B
(63)
Evomela
Plasma Cell Leukemia
National Cancer Institute (NCI)
P2
B
(63)
FILGRASTIM
AIDS-related Peripheral/Systemic Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
Showing 501 to 525 of 4,361 assets
Previous
Page 21 of 175
Next